Results 161 to 170 of about 509,198 (290)
Journal of Applied Clinical Medical Physics, EarlyView.Abstract Purpose An evaluation of the accuracy, safety, and efficiency of the Halcyon ring delivery system (RDS) for stereotactic radiosurgery (SRS) treatment to relatively small (1–3 cm) brain lesions. Methods After completing the extensive in‐house quality assurance checks including Winston–Lutz test and independent dose verification via MD Anderson ...
Kate Hazelwood +5 more
wiley +1 more source
PCV7: COST-UTILITY ANALYSIS OF DRUG THERAPY OPTIONS FOR INTERMITTENT CLAUDICATION
, 2001 WF McGhan
openalex +1 more source
Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis [PDF]
, 2004 Dan Greenberg +5 more
openalex +1 more source
Effect of Stroke Unit for Patients with Ruptured Cerebral Aneurysms: A Cost-utility Analysis.
, 2001 Akihiro Toyota +7 more
openalex +2 more sources
A cost-utility analysis of adjunctive treatment with newer antiepileptic drugs in the UK [PDF]
, 2004 Edit Remák +4 more
openalex +1 more source
Handling rescue therapy in myasthenia gravis clinical trials: why it matters and why you should care
Annals of Clinical and Translational Neurology, EarlyView.Abstract Myasthenia gravis (MG) clinical trials typically allow rescue therapy during follow‐up in the event of marked worsening of MG symptoms. Failure to appropriately address rescue therapy in defining treatment effects and planning statistical analyses may yield biased estimates, increase false positive rates, or decrease statistical power – all of
Justin M. Leach +3 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.Abstract Objectives Intravenous immunoglobulin (IVIg) is an effective treatment for Guillain–Barré syndrome (GBS), but recovery varies between patients. This study aims to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of a single and a second IVIg dose (SID) in patients with GBS.
Sander J. van Tilburg +7 more
wiley +1 more source